Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without Diabetes
Background Dysglycemia at acute myocardial infarction (AMI) is common and is associated with mortality. Information on other outcomes is less well explored in patients without diabetes in a long‐term perspective. We aimed to explore the relationship between admission glucose level and long‐term outc...
Enregistré dans:
Auteurs principaux: | Viveca Ritsinger, Emil Hagström, Bo Lagerqvist, Anna Norhammar |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wiley
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/876e4b8dbd8b4c73968a9deae4dd1f65 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Role of Environmental PM2.5 in Admission Acute Heart Failure in ST-Elevation Myocardial Infarction patients - An Observational Retrospective Study
par: Sinkovic A, et autres
Publié: (2021) -
A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure
par: Pema Raj, et autres
Publié: (2021) -
Long-Term Pharmacological Management of Reduced Ejection Fraction Following Acute Myocardial Infarction: Current Status and Future Prospects
par: Abel AAI, et autres
Publié: (2021) -
The effect of empagliflozin on the development of chronic heart failure after myocardial infarction according to a 12-month prospective study
par: Alexey A. Nekrasov, et autres
Publié: (2019) -
Protective role of emodin in rats with post-myocardial infarction heart failure and influence on extracellular signal-regulated kinase pathway
par: Jinfeng Liu, et autres
Publié: (2021)